Siegfried Holding AG (0QQO.L) LSE

78.28

-0.01701(-0.02%)

Updated at September 26 06:28PM

Currency In CHF

Siegfried Holding AG

Address

Untere Bruehlstrasse 4

Zofingen, 4800

Switzerland

Phone

41 62 746 1111

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

3886

First IPO Date

October 13, 2014

Key Executives

NameTitlePayYear Born
Mr. Marcel ImwinkelriedChief Executive Officer & Chief Operating Officer Drug Products ad interim1.29M1967
John JonesHead of Operations - Malta0N/A
Beatrice HarderHead Regulatory Affairs - Site Zofingen0N/A
Ms. Marianne SpaneChief Business Officer of Drug Substances & Drug Products01962
Mr. Stefan RandlChief Scientific Officer0N/A
Dr. Reto Suter Ph.D.Chief Financial Officer01971
Mr. Peter StierliHead of Corporate Communications0N/A
Ms. Olesia SilantevaChief Human Resources Officer01982
Dr. Luca Dalla TorreChief Legal & Sustainability Officer0N/A
Mr. Enno Schweinberger Ph.D.Head Global Quality Management DS - Zofingen0N/A

Description

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.